SIMILAR PATTERNS OF AMINO ACIDS FOR 5V21_A_SAMA1804

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mvh CRYPTIC LOCI
REGULATOR 4

(Schizosaccharomyces
pombe) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 GLY A 339
TRP A 340
TYR A 381
ASN A 409
HIS A 410
 None
 0.54A 5v21A-1mvhA:
16.0		 5v21A-1mvhA:
30.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1mvh CRYPTIC LOCI
REGULATOR 4

(Schizosaccharomyces
pombe) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 LYS A 338
GLY A 339
TYR A 381
ASN A 409
HIS A 410
 None
 1.15A 5v21A-1mvhA:
16.0		 5v21A-1mvhA:
30.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 GLY A 160
TRP A 161
ASN A 241
HIS A 242
TYR A 283
CYH A 308
 SAH  A 319 ( 4.6A)
SAH  A 319 (-4.8A)
SAH  A 319 (-3.6A)
SAH  A 319 (-4.3A)
SAH  A 319 (-4.7A)
ZN  A   4 (-2.2A)
 1.20A 5v21A-1pegA:
18.1		 5v21A-1pegA:
29.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1peg HISTONE H3
METHYLTRANSFERASE
DIM-5

(Neurospora
crassa) 		PF00856
(SET)
PF05033
(Pre-SET) 		8 GLY A 160
TRP A 161
TYR A 204
ASN A 241
HIS A 242
TYR A 283
CYH A 306
LEU A 317
 SAH  A 319 ( 4.6A)
SAH  A 319 (-4.8A)
SAH  A 319 (-4.0A)
SAH  A 319 (-3.6A)
SAH  A 319 (-4.3A)
SAH  A 319 (-4.7A)
ZN  A   4 ( 2.3A)
SAH  A 319 (-3.9A)
 0.76A 5v21A-1pegA:
18.1		 5v21A-1pegA:
29.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y9i LOW TEMPERATURE
REQUIREMENT C
PROTEIN

(Listeria
monocytogenes) 		PF04608
(PgpA) 		5 GLY A  42
TYR A  39
TYR A 162
GLN A  36
LEU A 158
 None
 1.42A 5v21A-1y9iA:
undetectable		 5v21A-1y9iA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r3a HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV39H2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 GLY A 151
TRP A 152
HIS A 220
TYR A 261
CYH A 289
 SAM  A 304 (-3.5A)
None
SAM  A 304 (-4.9A)
SAM  A 304 (-4.9A)
ZN  A 300 ( 2.3A)
 1.30A 5v21A-2r3aA:
18.5		 5v21A-2r3aA:
28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r3a HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV39H2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		8 GLY A 151
TRP A 152
TYR A 193
ASN A 219
HIS A 220
TYR A 261
CYH A 287
LEU A 298
 SAM  A 304 (-3.5A)
None
SAM  A 304 (-4.2A)
SAM  A 304 (-3.3A)
SAM  A 304 (-4.9A)
SAM  A 304 (-4.9A)
ZN  A 300 ( 2.3A)
SAM  A 304 (-4.7A)
 0.59A 5v21A-2r3aA:
18.5		 5v21A-2r3aA:
28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r3a HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV39H2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 GLY A 153
TYR A 193
HIS A 220
TYR A 261
CYH A 287
LEU A 298
 None
SAM  A 304 (-4.2A)
SAM  A 304 (-4.9A)
SAM  A 304 (-4.9A)
ZN  A 300 ( 2.3A)
SAM  A 304 (-4.7A)
 1.42A 5v21A-2r3aA:
18.5		 5v21A-2r3aA:
28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w5z HISTONE-LYSINE
N-METHYLTRANSFERASE
HRX

(Homo sapiens) 		PF00856
(SET) 		6 GLY A3840
ASN A3906
HIS A3907
TYR A3944
CYH A3957
LEU A3968
 SAH  A4971 ( 3.7A)
SAH  A4971 (-3.1A)
SAH  A4971 (-4.7A)
SAH  A4971 (-4.9A)
ZN  A4970 ( 2.3A)
SAH  A4971 ( 4.9A)
 0.41A 5v21A-2w5zA:
14.4		 5v21A-2w5zA:
27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w5z HISTONE-LYSINE
N-METHYLTRANSFERASE
HRX

(Homo sapiens) 		PF00856
(SET) 		5 GLY A3840
ASN A3906
HIS A3907
TYR A3944
CYH A3959
 SAH  A4971 ( 3.7A)
SAH  A4971 (-3.1A)
SAH  A4971 (-4.7A)
SAH  A4971 (-4.9A)
ZN  A4970 (-2.3A)
 1.19A 5v21A-2w5zA:
14.4		 5v21A-2w5zA:
27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w5z HISTONE-LYSINE
N-METHYLTRANSFERASE
HRX

(Homo sapiens) 		PF00856
(SET) 		6 GLY A3840
TYR A3883
ASN A3906
HIS A3907
TYR A3944
CYH A3957
 SAH  A4971 ( 3.7A)
None
SAH  A4971 (-3.1A)
SAH  A4971 (-4.7A)
SAH  A4971 (-4.9A)
ZN  A4970 ( 2.3A)
 0.64A 5v21A-2w5zA:
14.4		 5v21A-2w5zA:
27.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 GLY A 138
TYR A 178
HIS A 210
TYR A 248
CYH A 273
LEU A 284
 None
SAH  A 305 (-4.0A)
None
SAH  A 305 (-4.9A)
ZN  A 304 ( 2.3A)
SAH  A 305 (-4.5A)
 1.23A 5v21A-3bo5A:
20.0		 5v21A-3bo5A:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 LYS A 135
GLY A 136
TRP A 137
HIS A 210
TYR A 248
CYH A 275
 None
SAH  A 305 (-3.8A)
None
None
SAH  A 305 (-4.9A)
ZN  A 304 ( 2.3A)
 1.35A 5v21A-3bo5A:
20.0		 5v21A-3bo5A:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bo5 HISTONE-LYSINE
N-METHYLTRANSFERASE
SETMAR

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		9 LYS A 135
GLY A 136
TRP A 137
TYR A 178
ASN A 209
HIS A 210
TYR A 248
CYH A 273
LEU A 284
 None
SAH  A 305 (-3.8A)
None
SAH  A 305 (-4.0A)
SAH  A 305 (-3.4A)
None
SAH  A 305 (-4.9A)
ZN  A 304 ( 2.3A)
SAH  A 305 (-4.5A)
 0.43A 5v21A-3bo5A:
20.0		 5v21A-3bo5A:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n71 HISTONE LYSINE
METHYLTRANSFERASE
SMYD1

(Mus musculus) 		PF00856
(SET)
PF01753
(zf-MYND) 		6 GLY A  18
TYR A 271
ASN A 205
HIS A 206
TYR A 252
CYH A 274
 SFG  A 491 ( 4.2A)
None
SFG  A 491 (-3.3A)
None
SFG  A 491 (-4.8A)
ZN  A 497 (-2.2A)
 1.13A 5v21A-3n71A:
5.7		 5v21A-3n71A:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n71 HISTONE LYSINE
METHYLTRANSFERASE
SMYD1

(Mus musculus) 		PF00856
(SET)
PF01753
(zf-MYND) 		6 LYS A  17
GLY A  16
TYR A 271
HIS A 206
TYR A 252
CYH A 274
 SFG  A 491 (-4.7A)
None
None
None
SFG  A 491 (-4.8A)
ZN  A 497 (-2.2A)
 1.50A 5v21A-3n71A:
5.7		 5v21A-3n71A:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n71 HISTONE LYSINE
METHYLTRANSFERASE
SMYD1

(Mus musculus) 		PF00856
(SET)
PF01753
(zf-MYND) 		6 LYS A  17
GLY A  18
TYR A 271
HIS A 206
TYR A 252
CYH A 274
 SFG  A 491 (-4.7A)
SFG  A 491 ( 4.2A)
None
None
SFG  A 491 (-4.8A)
ZN  A 497 (-2.2A)
 1.47A 5v21A-3n71A:
5.7		 5v21A-3n71A:
20.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ooi HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-36 AND H4
LYSINE-20 SPECIFIC

(Homo sapiens) 		PF00856
(SET) 		6 GLY A 102
TRP A 103
ASN A 169
HIS A 170
TYR A 207
CYH A 221
 SAM  A 237 ( 3.7A)
None
SAM  A 237 (-3.3A)
SAM  A 237 (-4.7A)
None
ZN  A 232 (-2.3A)
 1.09A 5v21A-3ooiA:
24.7		 5v21A-3ooiA:
37.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ooi HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-36 AND H4
LYSINE-20 SPECIFIC

(Homo sapiens) 		PF00856
(SET) 		8 GLY A 102
TRP A 103
TYR A 146
ASN A 169
HIS A 170
TYR A 207
CYH A 219
LEU A 230
 SAM  A 237 ( 3.7A)
None
SAM  A 237 (-4.1A)
SAM  A 237 (-3.3A)
SAM  A 237 (-4.7A)
None
ZN  A 232 ( 2.3A)
SAM  A 237 (-4.8A)
 0.57A 5v21A-3ooiA:
24.7		 5v21A-3ooiA:
37.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		5 GLY A2153
TYR A2194
HIS A2218
TYR A2255
CYH A2268
 None
SAM  A   7 (-3.4A)
None
None
ZN  A   1 ( 2.5A)
 1.37A 5v21A-3opeA:
24.2		 5v21A-3opeA:
37.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		7 LYS A2150
GLY A2151
TRP A2152
ASN A2217
HIS A2218
TYR A2255
CYH A2270
 None
SAM  A   7 (-3.4A)
None
SAM  A   7 (-3.9A)
None
None
ZN  A   1 (-2.7A)
 1.20A 5v21A-3opeA:
24.2		 5v21A-3opeA:
37.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ope PROBABLE
HISTONE-LYSINE
N-METHYLTRANSFERASE
ASH1L

(Homo sapiens) 		PF00856
(SET) 		9 LYS A2150
GLY A2151
TRP A2152
TYR A2194
ASN A2217
HIS A2218
TYR A2255
GLN A2266
CYH A2268
 None
SAM  A   7 (-3.4A)
None
SAM  A   7 (-3.4A)
SAM  A   7 (-3.9A)
None
None
SAM  A   7 (-2.9A)
ZN  A   1 ( 2.5A)
 0.48A 5v21A-3opeA:
24.2		 5v21A-3opeA:
37.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rc0 N-LYSINE
METHYLTRANSFERASE
SETD6

(Homo sapiens) 		PF00856
(SET)
PF09273
(Rubis-subs-bind) 		5 GLY A  74
TYR A 223
ASN A 251
HIS A 252
TYR A 285
 SAM  A 484 (-3.4A)
SAM  A 484 (-3.6A)
SAM  A 484 (-3.1A)
None
SAM  A 484 (-4.8A)
 0.88A 5v21A-3rc0A:
6.0		 5v21A-3rc0A:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c1q HISTONE-LYSINE
N-METHYLTRANSFERASE
PRDM9

(Mus musculus) 		PF00856
(SET) 		5 GLY A 257
TYR A 291
ASN A 320
TYR A 357
LEU A 365
 SAH  A 394 ( 3.7A)
SAH  A 394 (-3.9A)
SAH  A 394 (-3.4A)
None
SAH  A 394 ( 4.3A)
 0.56A 5v21A-4c1qA:
8.7		 5v21A-4c1qA:
18.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fmu HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD2

(Homo sapiens) 		PF00856
(SET) 		6 LYS A1560
GLY A1561
TRP A1562
ASN A1628
HIS A1629
CYH A1680
 None
0UM  A1804 (-3.5A)
None
0UM  A1804 (-3.3A)
None
ZN  A1803 (-2.2A)
 1.37A 5v21A-4fmuA:
34.3		 5v21A-4fmuA:
96.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fmu HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD2

(Homo sapiens) 		PF00856
(SET) 		10 LYS A1560
GLY A1561
TRP A1562
HIS A1603
TYR A1605
ASN A1628
HIS A1629
GLN A1676
CYH A1678
LEU A1689
 None
0UM  A1804 (-3.5A)
None
0UM  A1804 (-3.7A)
0UM  A1804 (-4.2A)
0UM  A1804 (-3.3A)
None
0UM  A1804 (-3.3A)
ZN  A1803 ( 2.2A)
0UM  A1804 (-4.8A)
 0.21A 5v21A-4fmuA:
34.3		 5v21A-4fmuA:
96.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fmu HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD2

(Homo sapiens) 		PF00856
(SET) 		9 LYS A1560
GLY A1561
TRP A1562
TYR A1604
TYR A1605
ASN A1628
GLN A1676
CYH A1678
LEU A1689
 None
0UM  A1804 (-3.5A)
None
UNX  A1805 (-4.8A)
0UM  A1804 (-4.2A)
0UM  A1804 (-3.3A)
0UM  A1804 (-3.3A)
ZN  A1803 ( 2.2A)
0UM  A1804 (-4.8A)
 1.07A 5v21A-4fmuA:
34.3		 5v21A-4fmuA:
96.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mi5 HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2

(Homo sapiens) 		PF00856
(SET) 		5 GLY A 628
TRP A 629
ASN A 693
HIS A 694
TYR A 731
 None
 0.90A 5v21A-4mi5A:
13.5		 5v21A-4mi5A:
28.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qeo HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-9 SPECIFIC
SUVH4

(Arabidopsis
thaliana) 		PF00856
(SET)
PF02182
(SAD_SRA)
PF05033
(Pre-SET) 		8 LYS A 456
GLY A 457
TRP A 458
ASN A 551
HIS A 552
TYR A 593
CYH A 612
LEU A 623
 SAH  A 801 (-4.7A)
SAH  A 801 (-3.6A)
SAH  A 801 (-4.9A)
SAH  A 801 (-3.2A)
None
None
ZN  A 805 ( 2.4A)
None
 0.59A 5v21A-4qeoA:
17.8		 5v21A-4qeoA:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qeo HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-9 SPECIFIC
SUVH4

(Arabidopsis
thaliana) 		PF00856
(SET)
PF02182
(SAD_SRA)
PF05033
(Pre-SET) 		6 LYS A 456
GLY A 457
TRP A 458
HIS A 552
TYR A 593
CYH A 614
 SAH  A 801 (-4.7A)
SAH  A 801 (-3.6A)
SAH  A 801 (-4.9A)
None
None
ZN  A 805 ( 2.4A)
 1.44A 5v21A-4qeoA:
17.8		 5v21A-4qeoA:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qeo HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-9 SPECIFIC
SUVH4

(Arabidopsis
thaliana) 		PF00856
(SET)
PF02182
(SAD_SRA)
PF05033
(Pre-SET) 		8 LYS A 456
GLY A 457
TYR A 493
ASN A 551
HIS A 552
TYR A 593
CYH A 612
LEU A 623
 SAH  A 801 (-4.7A)
SAH  A 801 (-3.6A)
SAH  A 801 (-4.0A)
SAH  A 801 (-3.2A)
None
None
ZN  A 805 ( 2.4A)
None
 0.38A 5v21A-4qeoA:
17.8		 5v21A-4qeoA:
21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qql COMPLEMENT C1Q-LIKE
PROTEIN 3

(Mus musculus) 		PF00386
(C1q) 		5 GLY A 121
HIS A 119
TYR A  92
HIS A  58
TYR A  94
 None
 1.29A 5v21A-4qqlA:
undetectable		 5v21A-4qqlA:
15.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w2r ENHANCER OF ZESTE 2
POLYCOMB REPRESSIVE
COMPLEX 2 SUBUNIT

(Anolis
carolinensis) 		no annotation 5 GLY A 520
TRP A 521
ASN A 585
HIS A 586
TYR A 623
 CJD  A 708 (-3.6A)
None
CJD  A 708 (-3.5A)
None
None
 0.75A 5v21A-4w2rA:
19.6		 5v21A-4w2rA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z4p HISTONE-LYSINE
N-METHYLTRANSFERASE
2D

(Homo sapiens) 		PF00856
(SET) 		5 GLY A5408
ASN A5474
HIS A5475
TYR A5512
CYH A5527
 SAH  A5602 (-3.6A)
SAH  A5602 (-3.1A)
None
None
ZN  A5601 ( 2.2A)
 1.10A 5v21A-4z4pA:
16.1		 5v21A-4z4pA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z4p HISTONE-LYSINE
N-METHYLTRANSFERASE
2D

(Homo sapiens) 		PF00856
(SET) 		6 GLY A5408
TYR A5451
ASN A5474
HIS A5475
TYR A5512
CYH A5525
 SAH  A5602 (-3.6A)
SAH  A5602 (-4.5A)
SAH  A5602 (-3.1A)
None
None
ZN  A5601 ( 2.2A)
 0.39A 5v21A-4z4pA:
16.1		 5v21A-4z4pA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f59 HISTONE-LYSINE
N-METHYLTRANSFERASE
2C

(Homo sapiens) 		PF00856
(SET) 		6 GLY A4782
TYR A4825
ASN A4848
HIS A4849
TYR A4886
CYH A4899
 SAH  A5002 (-3.5A)
SAH  A5002 (-4.5A)
SAH  A5002 (-2.7A)
SAH  A5002 (-4.6A)
None
ZN  A5001 ( 2.0A)
 0.61A 5v21A-5f59A:
15.7		 5v21A-5f59A:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f6l HISTONE-LYSINE
N-METHYLTRANSFERASE
2A

(Homo sapiens) 		PF00856
(SET) 		7 GLY A3840
TYR A3883
ASN A3906
HIS A3907
TYR A3944
CYH A3957
LEU A3968
 SAH  A4001 (-3.4A)
None
SAH  A4001 (-3.0A)
SAH  A4001 (-4.9A)
SAH  A4001 (-4.9A)
ZN  A4002 ( 2.3A)
None
 0.62A 5v21A-5f6lA:
16.0		 5v21A-5f6lA:
26.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kjm N-LYSINE
METHYLTRANSFERASE
SMYD2

(Homo sapiens) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 GLY A  18
ASN A 206
HIS A 207
TYR A 240
CYH A 262
 SAM  A 501 ( 4.1A)
SAM  A 501 (-3.2A)
None
6TM  A 502 ( 3.6A)
ZN  A 505 (-2.3A)
 0.47A 5v21A-5kjmA:
5.9		 5v21A-5kjmA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kjm N-LYSINE
METHYLTRANSFERASE
SMYD2

(Homo sapiens) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 HIS A 137
HIS A 207
TYR A 240
CYH A 262
LEU A 254
 SAM  A 501 (-3.9A)
None
6TM  A 502 ( 3.6A)
ZN  A 505 (-2.3A)
None
 1.11A 5v21A-5kjmA:
5.9		 5v21A-5kjmA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kjm N-LYSINE
METHYLTRANSFERASE
SMYD2

(Homo sapiens) 		PF00856
(SET)
PF01753
(zf-MYND) 		5 LYS A  17
GLY A  18
HIS A 207
TYR A 240
CYH A 262
 None
SAM  A 501 ( 4.1A)
None
6TM  A 502 ( 3.6A)
ZN  A 505 (-2.3A)
 1.05A 5v21A-5kjmA:
5.9		 5v21A-5kjmA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ls6 HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2,HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2,HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2

(Homo sapiens) 		PF00856
(SET)
PF11616
(EZH2_WD-Binding) 		5 GLY A 623
TRP A 624
ASN A 688
HIS A 689
TYR A 726
 74D  A 809 ( 3.9A)
None
74D  A 809 (-3.0A)
None
None
 0.91A 5v21A-5ls6A:
16.9		 5v21A-5ls6A:
17.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lsu HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD2

(Homo sapiens) 		PF00856
(SET) 		9 GLY A1074
TRP A1075
HIS A1116
TYR A1118
ASN A1141
HIS A1142
TYR A1179
CYH A1191
LEU A1202
 SAM  A1304 ( 3.2A)
None
SAM  A1304 (-3.4A)
SAM  A1304 (-3.8A)
SAM  A1304 (-2.9A)
SAM  A1304 (-4.6A)
SAM  A1304 (-4.1A)
ZN  A1301 ( 2.3A)
SAM  A1304 ( 4.7A)
 0.70A 5v21A-5lsuA:
25.1		 5v21A-5lsuA:
42.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lsu HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD2

(Homo sapiens) 		PF00856
(SET) 		6 GLY A1074
TRP A1075
TYR A1118
HIS A1142
TYR A1179
CYH A1193
 SAM  A1304 ( 3.2A)
None
SAM  A1304 (-3.8A)
SAM  A1304 (-4.6A)
SAM  A1304 (-4.1A)
ZN  A1301 (-2.3A)
 1.43A 5v21A-5lsuA:
25.1		 5v21A-5lsuA:
42.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5lsu HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD2

(Homo sapiens) 		PF00856
(SET) 		5 GLY A1076
TYR A1118
HIS A1142
TYR A1179
CYH A1193
 SAM  A1304 ( 4.6A)
SAM  A1304 (-3.8A)
SAM  A1304 (-4.6A)
SAM  A1304 (-4.1A)
ZN  A1301 (-2.3A)
 1.01A 5v21A-5lsuA:
25.1		 5v21A-5lsuA:
42.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5teg N-LYSINE
METHYLTRANSFERASE
KMT5A

(Homo sapiens) 		PF00856
(SET) 		6 LYS A 226
GLY A 227
TYR A 271
ASN A 298
HIS A 299
TYR A 336
 SAM  A 401 (-4.6A)
SAM  A 401 ( 4.0A)
SAM  A 401 (-4.1A)
SAM  A 401 (-3.2A)
None
SAM  A 401 (-4.8A)
 0.42A 5v21A-5tegA:
14.5		 5v21A-5tegA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tuy HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		5 GLY A1049
TRP A1050
ASN A1112
HIS A1113
CYH A1170
 SAM  A1505 ( 3.9A)
None
SAM  A1505 (-3.4A)
SAM  A1505 (-4.7A)
ZN  A1504 (-2.2A)
 1.10A 5v21A-5tuyA:
18.4		 5v21A-5tuyA:
28.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tuy HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT2

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A1049
TRP A1050
TYR A1085
ASN A1112
HIS A1113
TYR A1154
CYH A1168
 SAM  A1505 ( 3.9A)
None
SAM  A1505 (-4.0A)
SAM  A1505 (-3.4A)
SAM  A1505 (-4.7A)
SAM  A1505 (-4.9A)
ZN  A1504 (-2.2A)
 0.47A 5v21A-5tuyA:
18.4		 5v21A-5tuyA:
28.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vsd HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT1

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		7 GLY A1137
TRP A1138
TYR A1173
ASN A1200
HIS A1201
TYR A1242
CYH A1256
 SAM  A3001 (-3.6A)
None
SAM  A3001 (-4.0A)
SAM  A3001 (-3.4A)
SAM  A3001 (-4.6A)
SAM  A3001 (-4.8A)
ZN  A3005 ( 2.4A)
 0.54A 5v21A-5vsdA:
18.6		 5v21A-5vsdA:
28.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vsd HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT1

(Homo sapiens) 		PF00856
(SET)
PF05033
(Pre-SET) 		6 GLY A1137
TRP A1138
TYR A1173
HIS A1201
TYR A1242
CYH A1258
 SAM  A3001 (-3.6A)
None
SAM  A3001 (-4.0A)
SAM  A3001 (-4.6A)
SAM  A3001 (-4.8A)
ZN  A3005 (-2.3A)
 1.39A 5v21A-5vsdA:
18.6		 5v21A-5vsdA:
28.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wg6 HISTONE-LYSINE
N-METHYLTRANSFERASE
EZH2,POLYCOMB
PROTEIN SUZ12
(E.C.2.1.1.43)
CHIMERA

(Homo sapiens) 		no annotation 5 GLY A 623
TRP A 624
ASN A 688
HIS A 689
TYR A 726
 A9G  A9009 ( 4.2A)
None
A9G  A9009 (-3.1A)
None
None
 0.83A 5v21A-5wg6A:
17.2		 5v21A-5wg6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xxg -

(-) 		no annotation 5 GLY A  15
ASN A 205
HIS A 206
TYR A 239
CYH A 261
 SAM  A 502 ( 3.9A)
SAM  A 502 (-3.1A)
None
8HR  A 501 ( 4.0A)
ZN  A 503 (-2.2A)
 0.68A 5v21A-5xxgA:
5.9		 5v21A-5xxgA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c8s LOGANIC ACID
O-METHYLTRANSFERASE

(Catharanthus
roseus) 		no annotation 5 LYS A  39
GLY A  40
ASN A  83
TYR A  31
GLN A 316
 None
None
SAH  A 401 (-3.8A)
SAH  A 401 (-4.5A)
None
 1.40A 5v21A-6c8sA:
undetectable		 5v21A-6c8sA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6cen HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD3

(Homo sapiens) 		no annotation 8 GLY A1156
TRP A1157
TYR A1200
ASN A1223
HIS A1224
TYR A1261
CYH A1273
LEU A1284
 SAM  A1301 (-3.6A)
None
SAM  A1301 (-3.9A)
SAM  A1301 (-3.2A)
None
SAM  A1301 (-4.9A)
ZN  A1304 ( 2.3A)
SAM  A1301 (-4.6A)
 0.50A 5v21A-6cenA:
25.8		 5v21A-6cenA:
36.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6cen HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD3

(Homo sapiens) 		no annotation 6 GLY A1158
TYR A1200
HIS A1224
TYR A1261
CYH A1273
LEU A1284
 None
SAM  A1301 (-3.9A)
None
SAM  A1301 (-4.9A)
ZN  A1304 ( 2.3A)
SAM  A1301 (-4.6A)
 1.33A 5v21A-6cenA:
25.8		 5v21A-6cenA:
36.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6cen HISTONE-LYSINE
N-METHYLTRANSFERASE
NSD3

(Homo sapiens) 		no annotation 5 GLY A1158
TYR A1200
HIS A1224
TYR A1261
CYH A1275
 None
SAM  A1301 (-3.9A)
None
SAM  A1301 (-4.9A)
ZN  A1304 (-2.3A)
 1.05A 5v21A-6cenA:
25.8		 5v21A-6cenA:
36.40